Modulation of vesicle shedding in 8701 BC human breast carcinoma cells

Journal of Submicroscopic Cytology and Pathology

Volumn 30, Issue 1, 1998, Pages 45-53

  Cassara D ^c   Ginestra, A ^c   Dolo, V ^c   Miele, M ^c   Caruso, G ^c   Lucania, G ^c   Vittorelli, M L ^a,b  

^a Centre of Experimental Oncobiology   (Italy)

^b Dipartimento di Biologia Cellulare e dello Sviluppo   (Italy)

^c NONE

Author keywords

Breast cancer; Extracellular vesicles; Membrane shedding

Indexed keywords

8 BROMO CYCLIC AMP; 8 CHLORO CYCLIC ADENOSINE MONOPHOSPHATE; 8-CHLORO-CYCLIC ADENOSINE MONOPHOSPHATE; DRUG DERIVATIVE; PHOSPHOLIPASE A; QUERCETIN; RETINOIC ACID;

ARTICLE; BREAST TUMOR; CANCER INVASION; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL MEMBRANE; DRUG EFFECT; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; SECOND MESSENGER; SIGNAL TRANSDUCTION; ULTRASTRUCTURE;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL DIVISION; CELL MEMBRANE; EXTRACELLULAR MATRIX; FEMALE; HUMANS; MICROSCOPY, ELECTRON; NEOPLASM INVASIVENESS; PHOSPHOLIPASES A; QUERCETIN; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031608122     PISSN: 11229497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. ALEXANDER P., 1974. Escape from immune destruction by the host through shedding of surface antigens: Is this a characteristic shared by malignant and embryonic cells? Cancer Res., 34, 2077-2082.
2. ALLY S., TORTORA G., CLAIR T., GRIECO D., MERLO G., KATSAROS D., OGREID D., DOSKELAND S.O., JAHNSEN T. and CHO-CHUNG Y.S., 1988. Selective modulation of protein Kinase isozymes by the site-selective analog 8-cloroadenosine 3',5'-cyclic monophosphate provides a biological means for control of human colon cancer cell growth. Proc. Natl. Acad. Sci. USA, 85, 6319-6322.
3. BISWAS C., ZHANG Y., DE CASTRO R., GUO H., NAKAMURA T., KATAOKA H. and NEBESHIMA K., 1995. The human tumor cell-derived collageruse stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res., 55, 434-439.
4. CHIBA I., JIN R., HAMADA J., HOSOKAWA M., TAKEICHI N. and KOBAYASHI H., 1989. Growth-associated shedding of a tumor antigen (CE7) detected by a monoclonal antibody. Cancer Res., 49, 3972-3975.
5. COOPER D. and BARONDES S., 1990. Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. J. Cell Biol., 110, 1681-1691.
6. CURRIE G., 1976. Immunological aspects of host resistance to the development and growth of cancer. Biochim. Biophys. Acta, 458, 135-165.
7. CURRIE G. and ALEXANDER P., 1974. Spontaneous shedding of TSTA by sarcoma cells: its possible role in facilitating metastatic spread. Br. J. Cancer, 29, 72-75.
8. DAINIAK N., 1991. Surface membrane-associated regulation of cell assembly, differentiation and growth. Blood, 78, 264-276.
9. DAINIAK N. and SORBA S., 1991. Intracellular regulation of the production and release of human erythroid-directed lymphokines. J. Clin. Invest., 87, 213-219.
10. DOLJANSKI F. and KAPELLER M., 1976. Cell surface shedding: the phenomenon and its possible significance. J. Theor. Biol., 62, 253-270.
11. DOLO V., GINESTRA A., GHERSI G., NAGASE H. and VITTORELLI M.L., 1994. Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities. J. Submicrosc. Cytol. Pathol., 26, 173-180.
12. 3H-thymidine are neutralised by anti TGR-β antibodies. J. Submicrosc. Cytol. Pathol., 27, 535-541.
13. FOURCADE O., SIMON M.F., VIODÉ C., RUGANI N., LEBALLE F., RAGAB A., FOURNIÉ B., SARDA L. and CHAP H., 1995. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell, 80, 919-927.
14. GINESTRA A., MONEA S., SEGHEZZI G., DOLO V., NAGASE H., MIGNATTI P. and VITTORELLI M.L., 1997. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT-1080 fibrosarcoma cells. J. Biol. Chem., 272, 17216-17222.
15. LERNER M.P., LUCID S.W., WEN G.I. and NORDQUIST R.E., 1983. Selected area membrane shedding by tumor cells. Cancer Lett., 20, 125-130.
16. LIPPINCOTT-SCHWARTZ J., YUAN L.C., BONIFACINO J.S. and KLAUSNER R.D., 1989. Rapid redistribution of Golgi proteins into the ER in cells treated with Brefeldin A: Evidence for membrane cycling trom Golgi to ER. Cell, 56, 801-813.
17. JIANG C.G., TAYLOR D.D. and BLACK P.H., 1990. Effect of retinoic acid on tumor-mediated immunologic alterations in mice bearing a variant of the B16 melanoma. Int. J. Cancer, 46, 1054-1058.
18. LIPPMAN S.M., KESSLER J.F. and MEYSKENS F.L., 1987. Retinoids as preventive and therapeutic anticancer agents. Cancer Treat. Rep., 71, 391-405.
19. MASSAGUÉ J., HATA A. and LIU F., 1997. TGR-β signalling through the Smad pathway. Trends Cell Biol., 7, 187-192.
20. MAXFIELD F.R., WILLINGHAM M.C., DAVIES P.J.A. and PASTAN I., 1979. Amines inhibit the clustering of α2-macroglobulin and EGF on the fibroblast cell surface. Nature, 277, 661-663.
21. MINAFRA S., MORELLO V., GLORIOSO F., LA FIURA A., TOMASINO R.M., FEO S., MCINTOSH D. and WOLLEY D.E., 1989. A new cell line (8701-BC) from primary ductal infiltrating carcinoma of human breast. Br. J. Cancer, 60, 185-192.
22. MISUMI Y., MIKI K., TAKATSUKI A., TAMURA G. and IKEHARA Y., 1986. Novel blockade by Brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytcs. J. Biol. Chem., 261, 11398-11403.
23. MURAYAMA T. KATAOKA H., KOTTA H., NABESHIMA K. and KOONO M., 1991. Glycocalyces bodies in a human rectal carcinoma cell line and their interstitial collagenolytic activities. Virchows Arch. B Cell Pathol., 60, 265-270.
24. POSTE G. and NICOLSON G.L., 1980. Arrest and metastasis of blood-born tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc. Natl. Acad. Sci. USA, 77, 399-403.
25. RUBARTELLI A., COZZOLINO F., TALIO M. and SITIA R., 1990. A novel secretory pathway for Interleukin-1β, a protein lacking a signal sequence. EMBO J., 9, 1503-1510.
26. SINGHAL R.L., YEH Y.A., PRAJDA N., OLAH E., SLEDGE G.W. and WEBER G., 1995. Quercetin diwn-regulates signal transduction in human breast carcinoma cells. Biochem. Biophys. Res. Commun., 208, 425-431.
27. STEINMAN R.M., MELLMAN I.S., MULLER W.A. and COHN Z.A., 1983. Endocytosis and the recycling of plasma membrane. J. Cell Biol., 96, 1-27.
28. TARIN D., 1967. Sequential electron microscopical study of experimental mouse skin carcinogenesis. Int. J. Cancer, 2, 195-211.
29. TARIN D., 1969. Fine structure of murine mammary tumors: the relationship between epithelium and connective tissue in neoplasm induced by various agents. Br. J. Cancer, 23, 417-425.
30. TAYLOR D.D. and BLACK P.H., 1985. Inhibition of macrophages Ia antigen expression by shed plasma membrane vesicles from metastatic murine melanoma lines. J. Natl. Cancer Inst., 74, 859-867.
31. TAYLOR D.D. and BLACK P.H., 1986. Shedding oF plasma membrane fragments. Neoplastic and developmental importance. In: 'Developmental Biology'. Steinberg M. ed., Plenum Press, New York, vol. 3, pp. 33-57.
32. TAYLOR D.D., CHOU I.N. and BLACK P.H., 1983. Isolation of plasma membrane fragments from cultured murine melanoma cells. Biochem. Biophys. Res. Commun., 113, 470-476.
33. TAYLOR D.D., TAYLOR C.G., JIANG C.G. and BLACK P.H., 1988. Characterization of plasma membrane shedding from murine melanoma cells. Int. J. Cancer, 41, 629-635.
34. THIELE C.G., REYNOLDS C.P. and ISRAEL M.A., 1985. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature (London), 313, 404-406.
35. TUCK D.P., CERRETTI D.P., HAND A., GUHA A., SORBA S. and DAINIAK N., 1994. Human macrophage colony-stimulating factor is expressed at and shed from the cell surface. Blood, 84, 2182-2188.
36. VAN BLITTERSWIJK W.J., DE VEER G., KROL J.H. and EMMELOT P., 1982. Comparative lipid analysis of purified plasma membranes and shed extracellular membrane vesicles from normal murine thymocytes and leukaemia GRSL cells. Biochim. Biophys. Acta, 688, 496-504.
37. WAHL S.M., MCCARTNEY-FRANCIS N. and MARGENHAGEN S.E., 1989. Inflammatory and immunomodulatory roles of TGFβ. Immunol. Today, 10, 258-261.
38. WOLR G., 1984. Multiple functions of vitamin A. Physiol. Rev., 64, 873-937.
39. ZUCKER S., WIEMAN J.M., LYSIK R.M., WILKIE D.P., RAMAMURTHY N. and LANE B., 1987. Metastatic mouse melanoma cells release collagene-gelatin degrading metalloproteinases as components of shed membrane vesicles. Biochim. Biophys. Acta, 924, 225-237.